ARGENX SE is 8.1x more valuable than Vaxcyte, Inc. by market capitalization ($53.35 B vs $6.56 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PCVX | ARGX |
|---|---|---|
| Market cap | $6.56 B | $53.35 B |
| US-listed rank | #1196 | #306 |
| Net income (latest FY) | -$766.63K | - |
| SEC filings | 690 | 272 |
ARGENX SE is 8.1x more valuable than Vaxcyte, Inc. by market capitalization ($53.35 B vs $6.56 B).
Full pages: Vaxcyte, Inc. and ARGENX SE, or browse the full rankings.